My Region
Quad Cities
Sauk Valley
Tri-Counties
Western Illinois
News
Local
State
Illinois
Iowa
National
Border
Business
Energy
Entertainment
Health
National
Politics
Veterans
World
Music
AC
Active Rock
Alternative
CHR
Classic Hits/Oldies
Country
Hot AC
Rock
Submit News and Content
Agriculture
Brownfield Ag News
Ag Mid-Day Markets
Ag Closing Markets
Ag Commodity Week
Crime
Police Beat
Mugshots
National
Sports
National
College
High School
Athlete of the Month
Video
Weather
Local Weather
Closings & Cancellations
Submit Closings-Delays
Winter Driving Maps
Illinois
Iowa
Power Outages
Alliant
Ameren
Mid American
Obits
Obituaries
Submit to Obituaries
Community
All Events
Submit Your Event
Community Directory
Hometown Hope
Advertise
Buy NOW
Local Cause Marketing
Meet the Team
Listen – Watch
State Of Illinois
Clear 56°. Wind: NW 9 mph.
Closings/Delays
Submit Closing/Delay
My Region
Quad Cities
Sauk Valley
Tri-Counties
Western Illinois
News
Local
State
Illinois
Iowa
National
Border
Business
Energy
Entertainment
Health
National
Politics
Veterans
World
Music
AC
Active Rock
Alternative
CHR
Classic Hits/Oldies
Country
Hot AC
Rock
Submit News and Content
Agriculture
Brownfield Ag News
Ag Mid-Day Markets
Ag Closing Markets
Ag Commodity Week
Crime
Police Beat
Mugshots
National
Sports
National
College
High School
Athlete of the Month
Video
Weather
Local Weather
Closings & Cancellations
Submit Closings-Delays
Winter Driving Maps
Illinois
Iowa
Power Outages
Alliant
Ameren
Mid American
Obits
Obituaries
Submit to Obituaries
Community
All Events
Submit Your Event
Community Directory
Hometown Hope
Advertise
Buy NOW
Local Cause Marketing
Meet the Team
Listen – Watch
State Of Illinois
Search
Trending:
The Latest | Trump’s hush money trial enters 11th day as second week of testimony is set to wrap up
Home
Posts Tagged "drug"
( Page 2)
Stories tagged with: drug
Subscribe to the drug News Feed.
SHARE NOW
Wednesday, May 1
by
SRN News
GSK raises profit outlook on strong vaccine, HIV drug sales
By Eva Mathews and Maggie Fick (Reuters) -GSK raised its full-year profit forecast on Wednesday on strong demand for its common respiratory vaccine and specialty HIV medicines, though it expects sales growth to slow in the second half. CEO Emma Walmsley’s strategy has focussed on ...
Tuesday, April 30
by
SRN News
Neurocrine Biosciences’ Huntington’s disease drug gets FDA approval
(Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences’ INGREZZA drug to treat movement disorders associated with Huntington’s disease, the company said on Tuesday. Huntington’s disease is an inherited condition that causes the progressive breakdown of nerve cells ...
Tuesday, April 30
by
ABC News
Four dead, more than 50 suspected drug overdoses in Austin outbreak: Officials
(AUSTIN, Texas) -- Officials in Austin, Texas, are investigating an "outbreak" of deadly drug overdoses spreading across the city.Austin-Travis County Emergency Medical Services (ATCEMS) and the Austin Police Department (APD) said they received a total of 51 calls for suspected overdoses as of Tuesday ...
Tuesday, April 30
by
SRN News
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug
By Tanay Dhumal (Reuters) -Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug. U.S.-listed shares of Cronos Group, Tilray Brands and Canopy Growth rose between 14.9% and 67.7%, while ETF AdvisorShares ...
Tuesday, April 30
by
SRN News
US drug enforcers to ease restrictions on cannabis, AP reports
(Reuters) – The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press reported on Tuesday, citing five people familiar with the matter. The agency’s proposal, which must be reviewed by the White House ...
Tuesday, April 30
by
SRN News
US drug control agency will move to reclassify marijuana in a historic shift, AP sources say
WASHINGTON (AP) — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country. The DEA’s proposal, which ...
Tuesday, April 30
by
SRN News
Incyte misses quarterly profit on weak sales of lead drug
(Reuters) – Incyte Corp on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cancer drug Jakafi, sending its shares down 2.4%. The company is working on strengthening its pipeline to counter competition from newly approved ...
Tuesday, April 30
by
SRN News
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
By Bhanvi Satija and Patrick Wingrove (Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly’s weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2 billion on Tuesday, lifting its shares nearly 6%. Lilly said it expects significant production ...
Tuesday, April 30
by
SRN News
Eli Lilly lifts 2024 sales view by $2 billion on weight-loss drug demand
(Reuters) -Eli Lilly raised its annual revenue forecast by $2 billion on Tuesday due to strong demand and plans to increase production of its weight-loss treatment Zepbound and related diabetes drug Mounjaro, lifting its shares about 7% premarket. Sky-rocketing demand for Mounjaro and ...
Tuesday, April 30
by
SRN News
Eli Lilly lifts profit view on diabetes and weight-loss drug strength
(Reuters) -Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment Zepbound and type 2 diabetes drug Mounjaro. Shares of the company rose 3.6% premarket. Sky-rocketing demand for Mounjaro and Zepbound, both chemically known as tirzepatide, has propelled ...
Monday, April 29
by
SRN News
J&J, Bristol Myers lose challenges to US drug price negotiation program
By Brendan Pierson (Reuters) – A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government’s ...
Monday, April 29
by
SRN News
US FDA grants full approval for Pfizer’s cervical cancer drug
(Reuters) -The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer’s drug for treating cervical cancer patients whose disease had progressed on or after chemotherapy, the agency said on Monday. The treatment, Tivdak – an antibody-drug conjugate co-developed by Genmab A/S and ...
Previous
1
2
3
4
5
Next
Last